<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:05:34Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16171" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16171</identifier><datestamp>2026-10-18T20:30:58Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Effects of nicotine and vitamin E on glucose 6-phosphate dehydrogenase activity in some rat tissues in vivo and in vitro</dc:title><dc:creator>Gumustekin, Kenan</dc:creator><dc:creator>Ciftci, Mehmet</dc:creator><dc:creator>Coban, Abdulkadir</dc:creator><dc:creator>Altikat, Sayit</dc:creator><dc:creator>Aktas, Omer</dc:creator><dc:creator>Gul, Mustafa</dc:creator><dc:creator>Timur, Handan</dc:creator><dc:creator>Dane, Senol</dc:creator><dc:subject>Glucose 6-phosphate dehydrogenase</dc:subject><dc:subject>Inactivation</dc:subject><dc:subject>Inhibition</dc:subject><dc:subject>Nicotine</dc:subject><dc:subject>Rat tissues</dc:subject><dc:subject>Vitamin E</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Enzyme Inhibitors</dc:subject><dc:subject>Glucosephosphate Dehydrogenase</dc:subject><dc:subject>Organ Specificity</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Rats, Sprague-Dawley</dc:subject><dc:subject>Animalia</dc:subject><dc:subject>alpha tocopherol</dc:subject><dc:subject>glucose 6 phosphate dehydrogenase</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal tissue</dc:subject><dc:subject>article</dc:subject><dc:subject>brain homogenate</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>correlation function</dc:subject><dc:subject>drug mechanism</dc:subject><dc:subject>enzyme activation</dc:subject><dc:subject>enzyme activity</dc:subject><dc:subject>enzyme inactivation</dc:subject><dc:subject>enzyme inhibition</dc:subject><dc:subject>heart</dc:subject><dc:subject>in vitro study</dc:subject><dc:subject>in vivo study</dc:subject><dc:subject>kidney homogenate</dc:subject><dc:description>Effects of nicotine, and nicotine + vitamin E on glucose 6-phosphate dehydrogenase (G-6PD) activity in rat muscle, heart, lungs, testicle, kidney, stomach, brain and liver were investigated in vivo and in vitro on partially purified homogenates. Supplementation period was 3 weeks (n = 8 rats per group): nicotine [0.5 mg/kg/day, intraperitoneal (ip)]; nicotine + vitamin E [75 mg/kg/day, intragastric (ig)]; and control group (receiving only vehicle). The results showed that nicotine (0.5 mg/kg, ip) inhibited G-6PD activity in the lungs, testicle, kidney, stomach and brain by 12.5% (p &lt; 0.001), 48% (p &lt; 0.001), 20.8% (p &lt; 0.001), 13% (p &lt; 0.001) and 23.35% (p &lt; 0.001) respectively, and nicotine had no effects on the muscle, heart and liver G6PD activity. Also, nicotine + vitamin E inhibited G-6PD activity in the testicle, brain, and liver by 32.5% (p &lt; 0.001), 21.5% (p &lt; 0.001), and 16.5% (p &lt; 0.001) respectively, and nicotine + vitamin E activated the muscle, and stomach G-6PD activity by 36% (p &lt; 0.05), and 20% (p &lt; 0.001) respectively. In addition, nicotine + vitamin E did not have any effects on the heart, lungs, and kidney G-6PD activity. In addition, in vitro studies were also carried out to elucidate the effects of nicotine and vitamin E on G-6PD activity, which correlated well with in vivo experimental results in lungs, testicles, kidney, stomach, brain and liver tissues. These results show that vitamin E administration generally restores the inactivation of G-6PD activity due to nicotine administration in various rat tissues in vivo, and also in vitro. © 2005 Taylor &amp; Francis.</dc:description><dc:date>2005</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/16171</dc:identifier><dc:identifier>https://doi.org/10.1080/14756360500277384</dc:identifier><dc:identifier>1475-6374</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Enzyme Inhibition and Medicinal Chemistry</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16171</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>